163 related articles for article (PubMed ID: 21248239)
1. Neuronal FLT1 receptor and its selective ligand VEGF-B protect against retrograde degeneration of sensory neurons.
Dhondt J; Peeraer E; Verheyen A; Nuydens R; Buysschaert I; Poesen K; Van Geyte K; Beerens M; Shibuya M; Haigh JJ; Meert T; Carmeliet P; Lambrechts D
FASEB J; 2011 May; 25(5):1461-73. PubMed ID: 21248239
[TBL] [Abstract][Full Text] [Related]
2. Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration.
Poesen K; Lambrechts D; Van Damme P; Dhondt J; Bender F; Frank N; Bogaert E; Claes B; Heylen L; Verheyen A; Raes K; Tjwa M; Eriksson U; Shibuya M; Nuydens R; Van Den Bosch L; Meert T; D'Hooge R; Sendtner M; Robberecht W; Carmeliet P
J Neurosci; 2008 Oct; 28(42):10451-9. PubMed ID: 18923022
[TBL] [Abstract][Full Text] [Related]
3. VEGF-B selectively regenerates injured peripheral neurons and restores sensory and trophic functions.
Guaiquil VH; Pan Z; Karagianni N; Fukuoka S; Alegre G; Rosenblatt MI
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17272-7. PubMed ID: 25404333
[TBL] [Abstract][Full Text] [Related]
4. Neutralization of schwann cell-secreted VEGF is protective to in vitro and in vivo experimental diabetic neuropathy.
Taiana MM; Lombardi R; Porretta-Serapiglia C; Ciusani E; Oggioni N; Sassone J; Bianchi R; Lauria G
PLoS One; 2014; 9(9):e108403. PubMed ID: 25268360
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of VEGF and VEGF-derived peptide in peripheral neuropathies.
Verheyen A; Peeraer E; Lambrechts D; Poesen K; Carmeliet P; Shibuya M; Pintelon I; Timmermans JP; Nuydens R; Meert T
Neuroscience; 2013 Aug; 244():77-89. PubMed ID: 23583762
[TBL] [Abstract][Full Text] [Related]
6. Nuclear expression of FLT1 and its ligand PGF in FUS-DDIT3 carrying myxoid liposarcomas suggests the existence of an intracrine signaling loop.
Andersson MK; Göransson M; Olofsson A; Andersson C; Aman P
BMC Cancer; 2010 Jun; 10():249. PubMed ID: 20515481
[TBL] [Abstract][Full Text] [Related]
7. Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium.
Li X; Tjwa M; Van Hove I; Enholm B; Neven E; Paavonen K; Jeltsch M; Juan TD; Sievers RE; Chorianopoulos E; Wada H; Vanwildemeersch M; Noel A; Foidart JM; Springer ML; von Degenfeld G; Dewerchin M; Blau HM; Alitalo K; Eriksson U; Carmeliet P; Moons L
Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1614-20. PubMed ID: 18511699
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor-A165b prevents diabetic neuropathic pain and sensory neuronal degeneration.
Hulse RP; Beazley-Long N; Ved N; Bestall SM; Riaz H; Singhal P; Ballmer Hofer K; Harper SJ; Bates DO; Donaldson LF
Clin Sci (Lond); 2015 Oct; 129(8):741-56. PubMed ID: 26201024
[TBL] [Abstract][Full Text] [Related]
9. The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice.
Huusko J; Merentie M; Dijkstra MH; Ryhänen MM; Karvinen H; Rissanen TT; Vanwildemeersch M; Hedman M; Lipponen J; Heinonen SE; Eriksson U; Shibuya M; Ylä-Herttuala S
Cardiovasc Res; 2010 Apr; 86(1):122-30. PubMed ID: 19955220
[TBL] [Abstract][Full Text] [Related]
10. Engineered zinc finger protein-mediated VEGF-a activation restores deficient VEGF-a in sensory neurons in experimental diabetes.
Pawson EJ; Duran-Jimenez B; Surosky R; Brooke HE; Spratt SK; Tomlinson DR; Gardiner NJ
Diabetes; 2010 Feb; 59(2):509-18. PubMed ID: 19934008
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting heat-shock protein 90 reverses sensory hypoalgesia in diabetic mice.
Urban MJ; Li C; Yu C; Lu Y; Krise JM; McIntosh MP; Rajewski RA; Blagg BS; Dobrowsky RT
ASN Neuro; 2010 Aug; 2(4):e00040. PubMed ID: 20711301
[TBL] [Abstract][Full Text] [Related]
12. Expression of vascular endothelial growth factor (VEGF)-B and its receptor (VEGFR1) in murine heart, lung and kidney.
Muhl L; Moessinger C; Adzemovic MZ; Dijkstra MH; Nilsson I; Zeitelhofer M; Hagberg CE; Huusko J; Falkevall A; Ylä-Herttuala S; Eriksson U
Cell Tissue Res; 2016 Jul; 365(1):51-63. PubMed ID: 26928042
[TBL] [Abstract][Full Text] [Related]
13. Vasoinhibin Suppresses the Neurotrophic Effects of VEGF and NGF in Newborn Rat Primary Sensory Neurons.
Castillo X; Melo Z; Varela-Echavarría A; Tamariz E; Aroña RM; Arnold E; Clapp C; Martínez de la Escalera G
Neuroendocrinology; 2018; 106(3):221-233. PubMed ID: 28571011
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1.
Lee TH; Seng S; Sekine M; Hinton C; Fu Y; Avraham HK; Avraham S
PLoS Med; 2007 Jun; 4(6):e186. PubMed ID: 17550303
[TBL] [Abstract][Full Text] [Related]
15. The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.
Anisimov A; Leppänen VM; Tvorogov D; Zarkada G; Jeltsch M; Holopainen T; Kaijalainen S; Alitalo K
Sci Signal; 2013 Jul; 6(282):ra52. PubMed ID: 23821770
[TBL] [Abstract][Full Text] [Related]
16. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
17. VEGF is an autocrine/paracrine neuroprotective factor for injured retinal ganglion neurons.
Froger N; Matonti F; Roubeix C; Forster V; Ivkovic I; Brunel N; Baudouin C; Sahel JA; Picaud S
Sci Rep; 2020 Jul; 10(1):12409. PubMed ID: 32710087
[TBL] [Abstract][Full Text] [Related]
18. Suppressive effects of vascular endothelial growth factor-B on tumor growth in a mouse model of pancreatic neuroendocrine tumorigenesis.
Albrecht I; Kopfstein L; Strittmatter K; Schomber T; Falkevall A; Hagberg CE; Lorentz P; Jeltsch M; Alitalo K; Eriksson U; Christofori G; Pietras K
PLoS One; 2010 Nov; 5(11):e14109. PubMed ID: 21124841
[TBL] [Abstract][Full Text] [Related]
19. Endothelial nitric oxide synthase is strongly expressed in malignant mesothelioma but does not associate with vascular density or the expression of VEGF, FLK1 or FLT1.
Soini Y; Puhakka A; Kahlos K; Säily M; Pääkkö P; Koistinen P; Kinnula V
Histopathology; 2001 Aug; 39(2):179-86. PubMed ID: 11493335
[TBL] [Abstract][Full Text] [Related]
20. A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma.
Das B; Yeger H; Tsuchida R; Torkin R; Gee MF; Thorner PS; Shibuya M; Malkin D; Baruchel S
Cancer Res; 2005 Aug; 65(16):7267-75. PubMed ID: 16103078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
